Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 Jun;54(6):848-9; author reply 849-50.

Medications for obesity

Joel Lexchin, Ken Bassett, Pierre Biron, Peter Mansfield, Barbara Mintzes
Comment

Medications for obesity

Joel Lexchin et al. Can Fam Physician. 2008 Jun.
No abstract available

PubMed Disclaimer

Comment in

  • Editor's response.
    Kelsall DL. Kelsall DL. Can Fam Physician. 2008 Jun;54(6):850-1. Can Fam Physician. 2008. PMID: 18556489 Free PMC article. No abstract available.

Comment on

Similar articles

See all similar articles

References

    1. Sharma AM. A weighty issue. Medication as a cornerstone of medical obesity management. Can Fam Physician. 2008;54:498–9 (Eng). 500–1 (Fr). - PMC - PubMed
    1. Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev. 2003;(4):CD004094. - PubMed
    1. O’Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity. Health Technol Assess. 2001;5(18):1–81. - PubMed
    1. O’Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment. Health Technol Assess. 2002;6(6):1–97. - PubMed
    1. Curioni C, André C. Rimonabant for overweight or obesity. Cochrane Database Syst Rev. (4) 2006;18:CD006162. - PMC - PubMed

Substances